Search results
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 58 minutes agoJust days after Biogen Inc. announced it was buying Human Immunology Biosciences (HI-Bio) for $1.15...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 2 days agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...
Moderna’s long Covid plan
Politico· 5 days agoModerna is eyeing a new target: long Covid. The pharmaceutical company that became a household name when it developed a Covid-19 vaccine now wants to...
Selling US$3.3m Of Moderna Stock Rewarded Insiders
Simply Wall St. via Yahoo Finance· 7 days agoModerna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year are probably in a more...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 5 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 5 days agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, ...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 4 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 6 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Bird Flu Keeps Spreading in U.S. Cows. How Worried Should You Be?
Barrons.com· 5 hours agoO’Connell also said the agency is in conversation with mRNA-based vaccine manufacturers about making...